News Sentiment

XTLB sentiment intelligence

XTL Biopharmaceuticals Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 48 Balanced news tone 17 relevant articles
Exchange TLV Israel
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.80 Week of 19 Jun 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

87/100 classification confidence.

Company focus 17

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+5.9% over one week, -5.3% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

X T L Biopharmaceuticals Ltd

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 87/100 classification
One-week reaction 5.9% Price confirming higher
Trend fit Trend active -5.3% over four weeks
Fair value 1592.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 13
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 17
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingKey 9
TipRanks 2
Quiver Quantitative 2
Investing.com 1
Moomoo 1
Hargreaves Lansdown 1
StocksToTrade 1

Event Lens

What the news is about

Classified themes
Market update 13
Deals and strategy 3
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-17 of 17
TradingKey Direct company coverage

X T L Biopharmaceuticals Ltd

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 07:28
Source
TradingKey